Search Results - "Pandya, Pranav A."

Simultaneous enantioseparation and simulation studies of atenolol, metoprolol and propranolol on Chiralpak® IG column using supercritical fluid chromatography by Pandya, Pranav A., Shah, Priyanka A., Shrivastav, Pranav S.

“…Enantioseparation of three β-blockers, i.e., atenolol, metoprolol and propranolol, was studied on amylose tris(3-chloro-5-methylphenylcarbamate) immobilized…”
Get full text

Analytical separation of four stereoisomers of luliconazole using supercritical fluid chromatography: Thermodynamic aspects and simulation study with chiral stationary phase by Pandya, Pranav A., Shah, Priyanka A., Shrivastav, Pranav S.

“…•First report on selective separation of four stereoisomers of luliconazole using chiral SFC.•Separation efficiency was mainly dependent on the nature and…”
Get full text

Separation of achiral anti-diabetic drugs using sub/supercritical fluid chromatography with a polysaccharide stationary phase: Thermodynamic considerations and molecular docking study by Pandya, Pranav A., Shah, Priyanka A., Shrivastav, Pranav S.

“…[Display omitted] •Selective separation of four achiral anti-diabetic drugs on chiral stationary phase (CSP) by SFC.•Separation of drugs was mainly dependent…”
Get full text

Application of supercritical fluid chromatography for separation and quantitation of 15 co‐formulated binary anti‐hypertensive medications using a single elution protocol by Pandya, Pranav A., Shah, Priyanka A., Shrivastav, Pranav S.

“…A facile supercritical fluid chromatography method is proposed to analyse 15 co‐formulated binary anti‐hypertensive drug combinations using a customized…”
Get full text

Facile separation of four co-formulated ternary antihypertensive drug combinations with a customized elution protocol using supercritical fluid chromatography by Pandya, Pranav A., Shah, Priyanka A., Shrivastav, Pranav S.

“…•A customized elution protocol was used for separation of four co-formulated ternary combinations.•Thermodynamic study revealed enthalpy driven process for the…”
Get full text

Design, synthesis and biological evaluation of novel 5-(4-chlorophenyl)-4-phenyl-4H-1,2,4-triazole-3-thiols as an anticancer agent by Patel, Krupa R., Brahmbhatt, Jpan G., Pandya, Pranav A., Daraji, Drashti G., Patel, Hitesh D., Rawal, Rakesh M., Baran, Sujit K.

“…•Structure-based designing approach was used to identify novel 1,2,4-triazole-3-thiols as p53-MDM2 inhibitor.•Compounds were characterized by spectroscopic…”
Get full text

Novel N-thioamide analogues of pyrazolylpyrimidine based piperazine: Design, synthesis, characterization, in-silico molecular docking study and biological evaluation by Vekariya, Mayur K., Patel, Dhaval B., Pandya, Pranav A., Vekariya, Rajesh H., Shah, Prapti U., Rajani, Dhanji P., Shah, Nisha K.

“…Utilizing molecular hybridization approach, a progression of novel pyrazolylpyrimidine based N-thioamide derivatives of piperazine were identified in an effort…”
Get full text

Design, Synthesis and Biological Evaluation of Novel 5‐Phenyl‐5‐(thiophen‐2‐yl)‐4H‐1,2,4‐triazole‐3‐thiols as an Anticancer Agent by Patel, Krupa R., Brahmbhatt, Jpan G., Pandya, Pranav A., Bhadresha, Kinjal, Daraji, Drashti G., Patel, Hitesh D., Rawal, Rakesh M., Baran, Sujit K., Jayanthi, Sivaraman

“…Tumor suppressor protein p53 is one of the most appealing targets for targeted anticancer therapy, due to its significant role in cancer prevention and…”
Get full text

Design, Synthesis and Biological Evaluation of Novel 5‐Phenyl‐5‐(thiophen‐2‐yl)‐4 H ‐1,2,4‐triazole‐3‐thiols as an Anticancer Agent by Patel, Krupa R., Brahmbhatt, Jpan G., Pandya, Pranav A., Bhadresha, Kinjal, Daraji, Drashti G., Patel, Hitesh D., Rawal, Rakesh M., Baran, Sujit K., Jayanthi, Sivaraman

“…Abstract Tumor suppressor protein p53 is one of the most appealing targets for targeted anticancer therapy, due to its significant role in cancer prevention…”
Get full text

First‐trimester ultrasound detection of fetal heart anomalies: systematic review and meta‐analysis by Karim, J. N., Bradburn, E., Roberts, N., Papageorghiou, A. T., Papageorghiou, Aris T., Alfirevic, Zarko, Chudleigh, Trish, Goodman, Hilary, Ioannou, Christos, Longworth, Heather, Karim, Jehan N., Nicolaides, Kypros H., Pandya, Pranav, Smith, Gordon, Thilaganathan, Basky, Thornton, Jim, Rivero‐Arias, Oliver, Campbell, Helen, Juszczak, Ed, Linsell, Louise, Wilson, Ed, Hinton, Lisa, Fisher, Jane, Duff, Elizabeth, Rhodes, Anne, Yaz, Gil

“…ABSTRACT Objectives To determine the diagnostic accuracy of ultrasound at 11–14 weeks' gestation in the detection of fetal cardiac abnormalities and to…”
Get full text

Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn by Moise, Kenneth J., Ling, Leona E., Oepkes, Dick, Tiblad, Eleonor, Verweij, E.J.T. Joanne, Lopriore, Enrico, Smoleniec, John, Sachs, Ulrich J., Bein, Gregor, Kilby, Mark D., Miller, Russell S., Devlieger, Roland, Audibert, François, Emery, Stephen P., Markham, Kara, Norton, Mary E., Ocón-Hernández, Olga, Pandya, Pranav, Pereira, Leonardo, Silver, Robert M., Windrim, Rory, Streisand, James B., Leu, Jocelyn H., Mirza, Arpana, Smith, Valerie, Schwartz, Lisa B., Tjoa, May Lee, Saeed-Khawaja, Shumyla, Komatsu, Yosuke, Bussel, James B.

“…In a trial involving 13 pregnancies at high risk for early-onset severe hemolytic disease of the fetus and newborn, nipocalimab increased the percentage with…”
Get full text

Detection of non‐cardiac fetal abnormalities on ultrasound at 11–14 weeks: systematic review and meta‐analysis by Karim, J. N., Di Mascio, D., Roberts, N., Papageorghiou, A. T., Papageorghiou, Aris T, Alfirevic, Zarko, Chudleigh, Trish, Goodman, Hilary, Ioannou, Christos, Longworth, Heather, Karim, Jehan, Nicolaides, Kypros, Pandya, Pranav, Smith, Gordon, Thilaganathan, Basky, Thornton, Jim, Rivero‐Arias, Oliver, Campbell, Helen, Juszczak, Ed, Linsell, Louise, Wilson, Ed, Hinton, Lisa, Fisher, Jane, Duff, Elizabeth, Rhodes, Anne, Yaz, Gil

“…ABSTRACT Objectives To assess the diagnostic accuracy of two‐dimensional ultrasound at 11–14 weeks' gestation as a screening test for individual fetal…”
Get full text

Fetal lower urinary tract obstruction: international Delphi consensus on management and core outcomes set by Mustafa, H J, Khalil, A, Johnson, S, Gordijn, S J, Ganzevoort, W, Melling, C, Koh, C J, Mandy, G T, Kilby, M D, Johnson, A, Quintero, R A, Ryan, G, Shamshirsaz, A A, Nassr, A

“…To reach a Delphi-generated international expert consensus on the diagnosis, prognostic, management, and core outcome set (COS) of fetal Lower Urinary Tract…”
Get full text

Fetal Medicine: Basic Science and Clinical Practice by Pandya, Pranav P, Wapner, Ronald, Oepkes, Dick, Sebire, Neil

Get full text

Ethical Issues in Maternal-Fetal Medicine by Dondorp, Wybo J, de Wert, Guido M

Get full text

Neonatal Management and Outcome in Extreme Prematurity by Lopriore, Enrico, Te Pas, Arjan B, Steggerda, Sylke, van Klink, Jeanine M

Get full text

Kidney and Urinary Tract Disorders by Devlieger, Roland, Hindryckx, An

Get full text

Fetal Growth and Growth Restriction by Su, Emily J, Galan, Henry L

Get full text

Placental Function in Maternofetal Exchange by Sibley, Colin, Dilworth, Mark

Get full text

Lung Growth and Maturation by Harding, Richard, McDougall, Annie R.A, Hooper, Stuart B

Get full text